- Home
- CNTB vs ROMA Comparison
CNTB vs ROMA Comparison
Compare CNTB & ROMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | CNTB | ROMA |
|---|---|---|
| Founded | 2012 | 2018 |
| Country | United States | Hong Kong |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Savings Institutions |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 128.6M | 134.6M |
| IPO Year | 2020 | 2022 |
Fundamental Metrics
Financial Performance| Metric | CNTB | ROMA |
|---|---|---|
| Price | $3.02 | $4.66 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $8.50 | N/A |
| AVG Volume (30 Days) | ★ 110.9K | 67.6K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 75.22 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $26,033,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $24,617.69 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.51 | $0.67 |
| 52 Week High | $3.28 | $8.88 |
Technical Indicators
Market Signals| Indicator | CNTB | ROMA |
|---|---|---|
| Relative Strength Index (RSI) | 62.63 | 79.14 |
| Support Level | $2.30 | $1.95 |
| Resistance Level | $3.23 | $8.88 |
| Average True Range (ATR) | 0.18 | 0.45 |
| MACD | 0.03 | 0.21 |
| Stochastic Oscillator | 92.17 | 94.30 |
Price Performance
Historical ComparisonAbout CNTB Connect Biopharma Holdings Limited
Connect Biopharma Holdings Ltd is a clinical-stage company focused on the discovery and development of next-generation immune modulators for the treatment of serious autoimmune diseases and inflammation. It has leveraged its expertise in the biology of T cell modulation to build a portfolio of drug candidates consisting of small molecules and antibodies targeting critical pathways of inflammation. Its pipeline includes CBP-201, CBP-307 and CBP-174.
About ROMA Roma Green Finance Limited
Roma Green Finance Ltd is principally engaged in the provision of ESG, corporate governance and risk management as well as sustainability and climate change-related advisory services. The company works closely with its clients to help them understand, identify, manage, and overcome various business matters arising from such factors related to ESG, sustainability and climate change. Geographically, the company generates its revenue from Hong Kong and Singapore.